COMMUNIQUÉS West-GlobeNewswire

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018

14/08/2018 - 13:00

Second Product Program, NZV930 Enters Clinical Development CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation [...]

Neuronetics Reports Second Quarter 2018 Financial and Operating Results

14/08/2018 - 13:00

MALVERN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]

Athenex, Inc. Announces Second Quarter 2018 Results and Provides Corporate Update

14/08/2018 - 13:00

Second quarter revenue increased to $11.6 million compared to $4.6 million in the same period last year. Received a strategic investment of $100 million from Perceptive Advisors Primary endpoints achieved in two Phase 3 [...]

ReWalk Robotics Reports Second Quarter 2018 Financial Results

14/08/2018 - 13:00

— Total revenue of $1.8 million during the second quarter of 2018 — — VA updates national coverage policy which expands access to ReWalk exoskeletons — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Aug. 14, 2018 (GLOBE [...]

Sharps Compliance Reports Fiscal 2018 Fourth Quarter and Year End Results

14/08/2018 - 12:55

Fourth quarter 2018 revenue was $9.9 million with gross margin of 30% and net loss per share of $0.01 Unused Medication solutions business increased 62% Route-based business increased 21% Unused medication management [...]

Eyenovia Reports Second Quarter 2018 Financial Results

14/08/2018 - 12:30

NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]

HEXO Applauds the Ontario Governments Proposed Retail Framework

14/08/2018 - 12:30

GATINEAU, Quebec, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) supports the Ontario government’s announcement that they are planning a consultation for private [...]

HEXO applaudit le cadre de vente au détail proposé par le gouvernement de l’Ontario

14/08/2018 - 12:30

GATINEAU, Québec, 14 août 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX: HEXO) accueille avec joie l’annonce du gouvernement de l’Ontario concernant son projet de consultation sur [...]

Aptinyx Reports Second Quarter 2018 Financial and Business Results

14/08/2018 - 12:27

Completed upsized initial public offering that raised $117.8 million in gross proceeds EVANSTON, Ill., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing [...]

SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results

14/08/2018 - 12:00

SAN RAMON, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

TLC Doses First Patients in Phase I/II Trial of TLC590 for Postsurgical Pain Management

14/08/2018 - 10:55

TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO; “TLC”), a clinical-stage specialty pharmaceutical company dedicated to the development and [...]

C-RAD has appointed Cecilia Danckwardt-Lillieström as new CFO

14/08/2018 - 09:00

C-RAD today announces that Cecilia Danckwardt-Lillieström has been appointed Chief Financial Officer effective October 15, 2018, succeeding Therése Björklund who will assume another position within the finance [...]

Reminder Invitation C-RAD Web Presentation Half-Year Report 2018

14/08/2018 - 08:30

Presentation of the report for the first half of the fiscal year 2018: Date: Friday August 17, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-Year Report 2018 Procedure: Please register online through the [...]

Navamedic signs Sippi® agreement with Sweden's second largest county

14/08/2018 - 08:01

Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, announced today that it has entered a contract with Västra Götalands Regionen (VGR) on its proprietary digital urinmeter Sippi®. VGR [...]

Shire plc : Rule 2.9 Announcement

14/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 August 2018 [...]

Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections

14/08/2018 - 08:00

PDUFA action date set for February 13, 2019 NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today [...]

Curetis Announces Financial Results for the First Six Months of 2018

14/08/2018 - 07:39

Curetis Announces Financial Results for the First Six Months of 2018 - Successful U.S. launch of Unyvero System and LRT Application Cartridge, with strong pipeline of sales opportunities - Unyvero UTI Application [...]

Basilea reports half-year financial results reflecting strong in-market product sales growth in addition to progress and expansion of the R&D pipeline

14/08/2018 - 07:16

Total revenue increased by 30% to CHF 59.9 million; 2018 total revenue guidance is increased to CHF 120 - 130 million Royalties on Cresemba sales more than doubled to CHF 10.8 million Clinical oncology pipeline [...]

Curetis Announces Change in Curetis USA Inc. Management

14/08/2018 - 07:02

Curetis Announces Change in Curetis USA Inc. Management Christopher M. Bernard resigns as President & CEO of Curetis USA Inc. effective August 31, 2018 Chris D. Emery to succeed as President & CEO of Curetis USA [...]